These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12927956)

  • 1. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
    McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
    Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
    Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
    Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
    Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
    Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.
    Nikolskaia OV; de A Lima AP; Kim YV; Lonsdale-Eccles JD; Fukuma T; Scharfstein J; Grab DJ
    J Clin Invest; 2006 Oct; 116(10):2739-47. PubMed ID: 16998589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.
    Giroud M; Dietzel U; Anselm L; Banner D; Kuglstatter A; Benz J; Blanc JB; Gaufreteau D; Liu H; Lin X; Stich A; Kuhn B; Schuler F; Kaiser M; Brun R; Schirmeister T; Kisker C; Diederich F; Haap W
    J Med Chem; 2018 Apr; 61(8):3350-3369. PubMed ID: 29590750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
    Maiorana S; Ettari R; Previti S; Amendola G; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M
    ChemMedChem; 2020 Aug; 15(16):1552-1561. PubMed ID: 32567172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate inhibition and allosteric regulation by heparan sulfate of Trypanosoma brucei cathepsin L.
    Costa TF; dos Reis FC; Lima AP
    Biochim Biophys Acta; 2012 Mar; 1824(3):493-501. PubMed ID: 22234330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma brucei: Inhibition of cathepsin L is sufficient to kill bloodstream forms.
    Steverding D; Rushworth SA; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2020 Jan; 235():111246. PubMed ID: 31743688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei.
    Mackey ZB; O'Brien TC; Greenbaum DC; Blank RB; McKerrow JH
    J Biol Chem; 2004 Nov; 279(46):48426-33. PubMed ID: 15326171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei.
    Steverding D; Wang X; Sexton DW
    Parasitol Res; 2009 Oct; 105(5):1333-8. PubMed ID: 19609563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2 H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design.
    Giroud M; Kuhn B; Saint-Auret S; Kuratli C; Martin RE; Schuler F; Diederich F; Kaiser M; Brun R; Schirmeister T; Haap W
    J Med Chem; 2018 Apr; 61(8):3370-3388. PubMed ID: 29590751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug combination studies of curcumin and genistein against rhodesain of
    Ettari R; Previti S; Maiorana S; Allegra A; Schirmeister T; Grasso S; Zappalà M
    Nat Prod Res; 2019 Dec; 33(24):3577-3581. PubMed ID: 29897253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.